{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:22:07Z","timestamp":1783174927289,"version":"3.54.6"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2504601"],"award-info":[{"award-number":["2022YFC2504601"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-ZDLSF-41"],"award-info":[{"award-number":["2023-ZDLSF-41"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaut.2026.103574","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:36:39Z","timestamp":1778290599000},"page":"103574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanistic studies on the regulation of systemic sclerosis progression by imbalance in angiogenic T cell subsets"],"prefix":"10.1016","volume":"161","author":[{"given":"Haomiao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jaut.2026.103574_bib1","article-title":"From the grey area of pre-systemic sclerosis to very early disease and irreversible tissue damage: the challenge of defining at-risk patients for future preventive trials in systemic sclerosis","volume":"S0003\u20134967","author":"Lescoat","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103574_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/imr.13390","article-title":"Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: insights from other rheumatic diseases","volume":"328","author":"van Oostveen","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2026.103574_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41584-023-01032-1","article-title":"Back to the future: targeting the extracellular matrix to treat systemic sclerosis","volume":"19","author":"Leask","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2026.103574_bib5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2026.103574_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrrheum.2010.102","article-title":"Cellular and molecular aspects of vascular dysfunction in systemic sclerosis","volume":"6","author":"Trojanowska","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41584-023-01044-x","article-title":"Systemic sclerosis interstitial lung disease: unmet needs and potential solutions","volume":"20","author":"Liakouli","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/ard-2023-225415","article-title":"Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis","volume":"83","author":"Huang","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103574_bib9","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease","author":"Antoniou","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103574_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41584-025-01276-z","article-title":"Platelets as drivers of immunothrombosis in rheumatic diseases","volume":"21","author":"Maugeri","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102812","article-title":"Crosstalk between oxidative stress, mitochondrial dysfunction, chromosome instability, and the activation of the cGAS-STING\/IFN pathway in systemic sclerosis","volume":"110","author":"Waseem","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jaut.2026.103574_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2004.10.009","article-title":"Induction of endothelial cell damage by hCMV molecular mimicry","volume":"26","author":"Lunardi","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2026.103574_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66974-4","article-title":"Autoantibody landscape and functional role of anti-C-C motif chemokine receptor 8 autoantibodies in systemic sclerosis: post-hoc analysis of a B-cell depletion trial","volume":"16","author":"Matsuda","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2026.103574_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41577-024-01043-3","article-title":"Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice","volume":"24","author":"Nishide","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2026.103574_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41584-022-00803-6","article-title":"Assessment of disease outcome measures in systemic sclerosis","volume":"18","author":"Lafyatis","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib16","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.107.694778","article-title":"Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies","volume":"116","author":"Hur","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2026.103574_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1189\/jlb.5CE0815-335RR","article-title":"Editorial: senescent angiogenic T cells: the use of CD28 makes the difference in endothelial homeostasis","volume":"99","author":"Della Bella","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2026.103574_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0961203318821161","article-title":"Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors","volume":"28","author":"Cavazzana","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2026.103574_bib19","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.12659\/MSM.908406","article-title":"Circulating angiogenic T cells are increased in lupus nephritis patients","volume":"24","author":"Zhao","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jaut.2026.103574_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/biomedicines13010026","article-title":"The pathogenic role of expanded CD8+CD28null angiogenic T cells in ANCA-associated vasculitis","volume":"13","author":"Shen","year":"2024","journal-title":"Biomedicines"},{"issue":"Suppl 118","key":"10.1016\/j.jaut.2026.103574_bib21","first-page":"36","article-title":"Angiogenic T cells in primary Sj\u00f6gren\u2019s syndrome: a double-edged sword?","volume":"37","author":"Alunno","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/life13061259","article-title":"Detection of angiogenic T cells and endothelial progenitor cells in Beh\u00e7et disease and determination of their relationship with disease activity","volume":"13","author":"Kul","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.jaut.2026.103574_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13075-022-02930-7","article-title":"Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment","volume":"24","author":"Cafaro","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2026.103574_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/annrheumdis-2013-204250","article-title":"Angiogenic T cells are decreased in rheumatoid arthritis patients","volume":"74","author":"Rodr\u00edguez-Carrio","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103574_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1189\/jlb.5HI0215-042R","article-title":"Senescent profile of angiogenic T cells from systemic lupus erythematosus patients","volume":"99","author":"L\u00f3pez","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2026.103574_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1399856","article-title":"Integrated analysis of single-cell RNA-seq, bulk RNA-seq, Mendelian randomization, and eQTL reveals T cell-related nomogram model and subtype classification in rheumatoid arthritis","volume":"15","author":"Ding","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103574_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217243","article-title":"Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation: novel insights from single-cell RNA sequencing and spatial transcriptomics analyses","volume":"604","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jaut.2026.103574_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103574_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41584-025-01294-x","article-title":"Emerging therapies for the treatment of systemic sclerosis","volume":"21","author":"Distler","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41584-024-01217-2","article-title":"An international perspective on the future of systemic sclerosis research","volume":"21","author":"Abraham","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106282","article-title":"The risk of circulating angiogenic T cells and subsets in patients with systemic sclerosis","volume":"81","author":"Lv","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jaut.2026.103574_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.reth.2024.06.009","article-title":"Novel cell therapy with ex vivo cultured peripheral blood mononuclear cells significantly impacts angiogenesis in the murine ischemic limb model","volume":"26","author":"Furukawa","year":"2024","journal-title":"Regen. Ther."},{"key":"10.1016\/j.jaut.2026.103574_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.14283\/jfa.2024.38","article-title":"Circulating angiogenic and senescent T lymphocytes in ageing and frailty","volume":"13","author":"Byrne","year":"2024","journal-title":"J Frailty Aging"},{"key":"10.1016\/j.jaut.2026.103574_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103185","article-title":"T cell abnormalities in systemic sclerosis","volume":"21","author":"Jin","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2026.103574_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183102","article-title":"Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis","volume":"12","author":"Manetti","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103574_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-Cell therapy in autoimmune disease - a case series with Follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2026.103574_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"Suppl 106","key":"10.1016\/j.jaut.2026.103574_bib38","first-page":"3","article-title":"One year in review 2017: systemic sclerosis","volume":"35","author":"Barsotti","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0000000000000656","article-title":"Biomarkers in systemic sclerosis","volume":"31","author":"Skaug","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"issue":"Suppl 113","key":"10.1016\/j.jaut.2026.103574_bib40","first-page":"126","article-title":"The role of inflammatory markers in assessment of disease activity in systemic sclerosis","volume":"36","author":"Ross","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/BOR.0000000000000827","article-title":"Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment","volume":"33","author":"Arron","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108868","article-title":"Circulating CD31+ angiogenic T cells are reduced in prediabetes and increase with exercise training","volume":"38","author":"Baker","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jaut.2026.103574_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116264","article-title":"Prognostic value of angiogenic T cells in hepatitis B-induced liver cirrhosis","volume":"109","author":"He","year":"2024","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jaut.2026.103574_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111788","article-title":"Endothelial dysfunction and disease severity in COVID-19: insights from circulating Tang cell counts as a potential biomarker","volume":"130","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jaut.2026.103574_bib45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41584-024-01109-5","article-title":"Granzyme serine proteases in inflammation and rheumatic diseases","volume":"20","author":"Aubert","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103574_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70034","article-title":"An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis","volume":"12","author":"Pezeshkian","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.jaut.2026.103574_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206545","article-title":"Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis","volume":"13","author":"Hoffmann-Vold","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103574_bib48","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3390\/jcm9113388","article-title":"Potential biomarkers in systemic sclerosis: a literature review and update","volume":"9","author":"Utsunomiya","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2026.103574_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/biom13020388","article-title":"Granzyme B in autoimmune skin disease","volume":"13","author":"Gleave","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaut.2026.103574_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1442913","article-title":"Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis","volume":"15","author":"Zinellu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103574_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1573397114666180809121005","article-title":"The role of vascular endothelial growth factor in systemic sclerosis","volume":"15","author":"Flower","year":"2019","journal-title":"Curr. Rheumatol. Rev."},{"key":"10.1016\/j.jaut.2026.103574_bib52","article-title":"CX3CL1 recruits NK cells into the central nervous system and aggravates brain injury of mice caused by Angiostrongylus cantonensis infection","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jaut.2026.103574_bib53","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.3390\/ijms25084451","article-title":"Alterations in CX3CL1 levels and its role in viral pathogenesis","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2026.103574_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1371323","article-title":"Induction of CX3CL1 expression by LPS and its impact on invasion and migration in oral squamous cell carcinoma","volume":"12","author":"He","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jaut.2026.103574_bib55","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.1038\/s41598-024-59484-8","article-title":"Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis","volume":"14","author":"Lee","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2026.103574_bib56","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/eji.201747438","article-title":"CXCR4, but not CXCR3, drives CD8+ T-cell entry into and migration through the murine bone marrow","volume":"49","author":"Goedhart","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2026.103574_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.591386","article-title":"CXCR4 and CXCR7 signaling pathways: a focus on the cross-talk between cancer cells and tumor microenvironment","volume":"11","author":"Santagata","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jaut.2026.103574_bib58","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41467-018-03385-8","article-title":"A non-conserved amino acid variant regulates differential signalling between human and mouse CD28","volume":"9","author":"Porciello","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:03:48Z","timestamp":1783173828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"alternative-id":["S0896841126000521"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103574","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic studies on the regulation of systemic sclerosis progression by imbalance in angiogenic T cell subsets","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103574"}}